• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2023

Year: 2023

Stock News

Caterpillar Stock: Why I’m Not Constructive Going Into Earnings (NYSE:CAT)

January 31, 2023 admin 0

Marc Bruxelle/iStock Editorial via Getty Images Introduction Caterpillar Inc. (NYSE:CAT) is a Texas-based construction and mining equipment manufacturer that operates globally known for its bright yellow construction vehicles. Caterpillar’s products range from small backhoe loaders […]

Forex News

Australian Dollar Skips a Beat on Chinese PMI and Domestic Data. Where to for AUD/USD?

January 31, 2023 admin 0

Australian Dollar, AUD/USD, China PMI, Retail Sales, Credit, CPI, RBA – Talking Points The Australian Dollar inched north on improving Chinese PMI AUD/USD had been under pressure post soft retail sales and credit data Tuesday […]

Stock News

Starbucks Saw Ways To Fuel Growth (NASDAQ:SBUX)

January 31, 2023 admin 0

JohnFScott Starbucks (NASDAQ:SBUX) is currently traded at $109.02, nearly its 52-week high, 38.5x LTM P/E, which might have concerned and thereby demotivated investors from getting back in. This article will mainly talk about why I […]

Posts navigation

« 1 … 1,585 1,586 1,587 … 4,581 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Alpha Metallurgical Resources: Coal Is Here To Stay (NYSE:AMR)
    January 19, 2023 0
  • Why You Will Fail As A REIT Investor
    September 12, 2022 0
  • Penumbra, Inc. (PEN) Q3 2022 Earnings Call Transcript
    November 6, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.